NYSE ARCA | ETF
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index.
The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 4.36% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.85% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.51% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.47% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 3.43% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.31% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.24% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.23% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 3.16% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.07% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.01% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 2.88% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.88% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.87% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.85% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 1.68% |
| SAVA | Cassava Sciences Inc | Healthcare | Biotechnology | 1.62% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 1.47% |
| AMPH | Amphastar P | Healthcare | Drug Manufacturers - Specialty & Generic | 1.43% |